Related Concepts
Related Feeds
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Related Papers
[Rinshō ketsueki] The Japanese journal of clinical hematology
Kosuke TsuboiKiyoshi Ando
The Annals of Thoracic Surgery
M H Chamberlain, S A Nashef
Acta orthopaedica Belgica
Y Hallet, J Van Overschelde
La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris
B CanivetB Krebs
Leukemia & Lymphoma
Jan-Peter GlossmannAndreas Josting